comparemela.com
Home
Live Updates
CARsgens CT011 receives IND clearance from Chinas NMPA : comparemela.com
CARsgen's CT011 receives IND clearance from China's NMPA
CARsgen announced that its autologous CAR T-cell product candidate, CT011, received Investigational New Drug (IND) clearance from the NMPA in China.
Related Keywords
China ,
Huadong ,
Guangdong ,
Raffaele Baffa ,
,
Huadong Medicine ,
comparemela.com © 2020. All Rights Reserved.